Refining Management of Classical Hodgkin Lymphoma: What’s on the Horizon for Pediatric Management and AYA Survivorship
Released On
December 20, 2022
Expires On
December 20, 2023
Media Type
Internet
Completion Time
60 minutes
Specialty
Hematology-Oncology, Pathology, Pharmacy, Primary Care
Topic(s)
Lymphoma, Oncology
This activity is jointly provided by Global Education Group and PlatformQ Health Education, LLC, in collaboration with the National Organization for Rare Disorders, Inc (NORD).
This activity is supported an educational grant from Seagen Inc.
This activity was released on December 20, 2022 and is valid until December 20, 2023. Requests for credit must be made no later than December 20, 2023.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
- Physicians - maximum of 1.0 medical knowledge MOC point(s) in the American Board of Internal Medicine’s (ABIM)
- Nurses - maximum of 1.0 contact hour is provided by Global Education Group
Target Audience
The educational design of this activity addresses the needs of community-based and academic/specialist hematologists, hematologic oncologists, medical oncologists, hematopathologists, primary care providers, family practitioner internists, hematology/oncology nurses and nurse navigators, nurse practitioners, physician assistants, and pharmacists.
Program Overview
New treatments are poised to expand the armamentarium for pediatric classical Hodgkin lymphoma (cHL). Given the high rate of long-term survival in the pediatric population, treatment selection should consider any anticipated late toxicities associated with therapy, as well as long-term follow-up and survivorship plans that effectively facilitate the transition from pediatric to young-adult care.
Join a panel of experts in hematology-oncology to discuss relevant treatment options for pediatric patients with cHL and individualization of treatment based on risk status and the latest guidelines. Panelists will review emerging treatment options in clinical trials and share strategies to monitor for treatment-related late effects and preserve quality of life during the transition from pediatric to adult care.
Learning Objectives
After completing this activity, the participant should be better able to:
- Apply guideline- and evidence-based approaches to the management of patients with pediatric cHL
- Discuss the rationale for new therapies and the clinical data supporting their utilization in the pediatric cHL population
- Evaluate strategies to formulate long-term follow-up plans considering the transition from being a pediatric patient to adolescence and young adulthood
Faculty
Sharon M. Castellino, MD, MSc
Professor of Pediatrics
Emory University School of Medicine
Director, Leukemia and Lymphoma Program
Children's Healthcare of Atlanta
Chair, Hodgkin Lymphoma Committee
Children’s Oncology Group
Lisa Giulino Roth, MD
Associate Professor of Pediatrics
Director, Pediatric Oncology
Director, Adolescent and Young Adult Lymphoma Program
Weill Cornell Medical College
Vice Chair, Hodgkin Lymphoma Committee, Children’s Oncology Group
ACCREDITATION STATEMENT:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and PlatformQ Health Education, LLC. Global is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
PHYSICIAN CREDIT DESIGNATION
Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point(s) in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
NURSING CONTINUING EDUCATION
Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 1.0 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
DISCLOSURES OF RELEVANT FINANCIAL RELATIONSHIPS:
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
The planners and managers have the following relevant financial relationships with ineligible companies:
Rhys Williams, MSN, FNP-C, RN - Nothing to disclose
Lindsay Borvansky - Nothing to disclose
Andrea Funk - Nothing to disclose
Liddy Knight - Nothing to disclose
Ashley Cann - Nothing to disclose
Lauren Sinclair - Nothing to disclose
Tariqa Ackbarali - Nothing to disclose
Vandana Gupta - Nothing to disclose
Alissa Yost - Nothing to disclose
INSTRUCTIONS FOR PARTICIPATION AND CREDIT:
ESTIMATED TIME TO COMPLETE
This activity should take approximately 60 minutes to complete.
INSTRUCTIONS TO RECEIVE CREDIT
In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a score of 70% on the post-test.
FEE INFORMATION & REFUND/CANCELLATION POLICY
There is no fee for this educational activity.
COURSE VIEWING REQUIREMENTS:
HARDWARE/SOFTWARE REQUIREMENTS
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PlatformQ Health Education, LLC do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.
Technical Support:
For any technical issues or issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at Support@OMedLive.com
PlatformQ Health Privacy Policy:
By clicking “Start Activity” you are agreeing to PlatformQ Health’s privacy policy. PlatformQ Health takes your privacy very seriously. The full Privacy Policy found here describes (i) the types of information we collect from you when you visit our Site; (ii) how we use the information we collect; (iii) with whom and why we share it; and (iv) the choices we offer regarding our use of the information. We also describe how to contact us about our privacy practices.
Information we collect is primarily used to communicate with program participants, award CME/CE credits, manage user accounts, recommend relevant programs and perform data analysis to inform educational outcomes.
In plain English, here is what we affirm:
- You can change your registration profile at any time from our “Profile” page
- To request any of these changes without logging in, please call us at 1 (877) 394-1306 or email us at support@PlatformQHealth.com
- You can end your association with PlatformQ Health at any time
- PlatformQ Health does not spam, nor we do we rent or sell our email list in whole or in part. Any program-related data sharing is for engagement verification and opt-in based further education
- EU citizens can request a complete record of their account and/or request to have their personal data expunged by contacting support@PlatformQHealth.com with the subject line “Data Request”
You acknowledge and agree that by beginning this activity, you have affirmatively agreed to this Privacy Policy and consented to receiving electronic messages in conformance with this Privacy Policy. Please read the full privacy policy located at: www.platformqhealth.com/privacy-policy/